Vedolizumab (Entyvio) for NHS Scotland is supplied by Takeda UK
- Public Services Delivery Scotland
- Scotland
- 1 bid
Public Services Delivery Scotland awarded Takeda UK Limited a contract to supply vedolizumab, sold as Entyvio, to NHS Scotland.
The medicine goes to NHS Scotland bodies and Integrated Joint Boards. The agreement has a single supplier because of exclusive intellectual property rights. One bid was received, and the award went on lowest price.
The award was £47.9m in June 2026. The first term is one year, with an optional three-year extension that could take supply to June 2030.
- What
- Medicines supply
- Supplier
- Takeda UK Limited
- Value
- £47.9m
- How it was bought
- Not published
- 1 bid
- Dates and next
- 24 Jun 2026